Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 470

1.

Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.

Schuppan D, Schattenberg JM.

J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:68-76. doi: 10.1111/jgh.12212. Review.

PMID:
23855299
2.

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.

Younossi ZM.

Aliment Pharmacol Ther. 2008 Jul;28(1):2-12. doi: 10.1111/j.1365-2036.2008.03710.x. Epub 2008 Apr 11. Review.

3.

Role of diet and nutritional management in non-alcoholic fatty liver disease.

Fan JG, Cao HX.

J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.

PMID:
24251710
4.

[Non-alcoholic fatty liver disease--new view].

Raszeja-Wyszomirska J, Lawniczak M, Marlicz W, Miezyńska-Kurtycz J, Milkiewicz P.

Pol Merkur Lekarski. 2008 Jun;24(144):568-71. Review. Polish.

PMID:
18702346
5.

Non-alcoholic fatty liver disease.

Smith BW, Adams LA.

Crit Rev Clin Lab Sci. 2011 May-Jun;48(3):97-113. doi: 10.3109/10408363.2011.596521. Review.

PMID:
21875310
6.

Obesity and liver disease.

Scheen AJ, Luyckx FH.

Best Pract Res Clin Endocrinol Metab. 2002 Dec;16(4):703-16. Review.

7.

[Treatment of non-alcoholic fatty liver disease].

Koek GH.

Ned Tijdschr Geneeskd. 2011;155:A3181. Review. Dutch.

PMID:
21649947
8.

A fresh look at NASH pathogenesis. Part 1: the metabolic movers.

Larter CZ, Chitturi S, Heydet D, Farrell GC.

J Gastroenterol Hepatol. 2010 Apr;25(4):672-90. doi: 10.1111/j.1440-1746.2010.06253.x. Review.

PMID:
20492324
9.

Non-alcoholic fatty liver disease.

Tuyama AC, Chang CY.

J Diabetes. 2012 Sep;4(3):266-80. doi: 10.1111/j.1753-0407.2012.00204.x. Review.

PMID:
22564417
10.

[Nonalcoholic steatohepatitis: pathogenesis and treatment].

Park SH.

Korean J Hepatol. 2008 Mar;14(1):12-27. doi: 10.3350/kjhep.2008.14.1.12. Review. Korean.

11.

Non-alcoholic steatohepatitis.

Jansen PL.

Eur J Gastroenterol Hepatol. 2004 Nov;16(11):1079-85. Review. Erratum in: Eur J Gastroenterol Hepatol. 2005 Jul-Aug;63(7):241.

PMID:
15489564
12.

The epidemiology, pathogenesis and histopathology of fatty liver disease.

Levene AP, Goldin RD.

Histopathology. 2012 Aug;61(2):141-52. doi: 10.1111/j.1365-2559.2011.04145.x. Epub 2012 Feb 28. Review.

PMID:
22372457
13.

Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.

Tilg H, Moschen A.

Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67. Review.

PMID:
20485253
14.

Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.

Cusi K.

Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8. Review.

PMID:
22326434
15.

Non-alcoholic fatty liver disease from pathogenesis to management: an update.

Musso G, Gambino R, Cassader M.

Obes Rev. 2010 Jun;11(6):430-45. doi: 10.1111/j.1467-789X.2009.00657.x. Epub 2009 Oct 21. Review.

PMID:
19845871
16.

Nonalcoholic fatty liver disease in children.

Manco M, Bottazzo G, DeVito R, Marcellini M, Mingrone G, Nobili V.

J Am Coll Nutr. 2008 Dec;27(6):667-76. Review.

PMID:
19155426
17.

Non-alcoholic fatty liver disease.

Leclercq I.

Bull Mem Acad R Med Belg. 2010;165(3-4):147-55; discussion 155-8.

PMID:
21166266
18.

Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.

Milić S, Stimac D.

Dig Dis. 2012;30(2):158-62. doi: 10.1159/000336669. Epub 2012 Jun 20. Review.

PMID:
22722431
19.

Metabolic disturbances in non-alcoholic fatty liver disease.

Byrne CD, Olufadi R, Bruce KD, Cagampang FR, Ahmed MH.

Clin Sci (Lond). 2009 Apr;116(7):539-64. doi: 10.1042/CS20080253. Review.

PMID:
19243311
20.

Current and future therapeutic strategies in NAFLD.

Mark N, de Alwis W, Day CP.

Curr Pharm Des. 2010 Jun;16(17):1958-62. Review.

PMID:
20370671

Supplemental Content

Support Center